Chief Financial Officer
Current
Aug 2024 - Present
AeroLeads people directory · profile
Adam Bartnik Email & Phone Number
CFO | Finance Executive with 20+ years in BioPharma | FP&A | R&D | Controller | Shared Services | International Experience
at
Reprieve Cardiovascular
1 work email found
@vrtx.com
1 phone found area 212
LinkedIn matched
✓ Verified Jul 2026
4 data sources
Profile completeness 100%
Current company
Role
CFO | Finance Executive with 20+ years in BioPharma | FP&A | R&D | Controller | Shared Services | International Experience
Location
Greater Boston, United States
Who is Adam Bartnik? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Adam Bartnik is listed as CFO | Finance Executive with 20+ years in BioPharma | FP&A | R&D | Controller | Shared Services | International Experience at Reprieve Cardiovascular, based in Greater Boston, United States. AeroLeads shows a work email signal at vrtx.com, phone signal with area code 212, and a matched LinkedIn profile for Adam Bartnik.
Adam Bartnik previously worked as Chief Financial Officer at Reprieve Cardiovascular and Principal Consultant at Ascend Bio Advisors Llc. Adam Bartnik holds Master, Economics from Uniwersytet Marii Curie-Skłodowskiej W Lublinie.
Company email context
Email format at Reprieve Cardiovascular
This section adds company-level context without repeating Adam Bartnik's masked contact details.
{first}_{last}@vrtx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Adam Bartnik. Compare company email patterns before reaching out.
Profile bio
About Adam Bartnik
CFO | Finance Executive with 20+ years of experience in BioPharma industry | Hands-on leader with strong business acumen and analytical mindset | Proven record of scaling financial teams and global processes, including: Corporate FP&A, R&D FP&A with $2.5B+ budget, Controllers, Financial Reporting and Shared Services. Advocate for using technology to improve efficiency and insight, improving processes and systems to support business operations. • Strategic Planning and Resource Allocation• Extensive Business Partnering• FP&A end to end ownership (Forecasting, Budgeting, LRP, Monthly Reporting, KPI Analytics)• R&D Portfolio Analysis and Risk Management, Prioritization, R&D Committee• P&L management and Performance Analysis, Month End Closes• Financial and SEC Reporting (10-K, 10-Q, Earning Calls) • Controls design and review, SOX, non-GAAP committee • Financial Shared Services and process improvement• Financial Systems Implementations (SAP, Hyperion)• M&A, Acquisition target integrations (Celgene) and Change Management
Listed skills include Financial Reporting, Us Gaap, Consolidation, Sap, and 32 others.
Current workplace
Adam Bartnik's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles
Adam Bartnik work experience
A career timeline built from the work history available for this profile.
Principal Consultant
Current
Ascend Bio Advisors Llc
Apr 2024 - Present
Vice President, R&D Finance
Leading R&D FP&A group supporting EC members (CSO, CMO, EVP Head of Regulatory and Quality, including portfolio reviews, budgets, forecasts, long range plans for $2.5B OPEX• Strategic and tactical planning including resource allocation, risk management and portfolio prioritization• Scaled up team and processes to match increasing complexity and organization growth• Month end closes and reporting, internal controls, SOX, IA, CapEx• Regular financial health updates to EC, CEO, CFO and R&D Committee
Oct 2019 - Apr 2024
Vice President, Corporate Financial Planning & Analysis
• Leading Enterprise Budget and Forecasting processes and regularly appraising LT of company's financial standing• Working with Business Operations, Controllers, Treasury, Tax and Audit in creating comprehensive performance story, flag risks and provide options• Long term strategy planning including resource allocation, target setting and portfolio prioritization• Leading FP&A integration with Celgene
Feb 2019 - Oct 2019
Executive Director - Head Of Finance, R&D Portfolio Management And Analysis
• Leading R&D Portfolio $1.5B budget, projections, analysis, reporting and accounting• R&D Sustainability and Investment Prioritization• Streamlined processes to provide actionable financial analysis in half of the time and with 20% less staff
Jul 2016 - Feb 2019
Director Finance R&D Portfolio Analysis And Reporting
• Finance Lead, R&D Portfolio Management and Analysis• Portfolio Prioritization and sustainability analysis• FP&A Lead for Global Clinical Operations
Mar 2015 - Jun 2016
Director Of Consolidation And Financial Reporting (Sec)
• Increasing responsibilities leadership roles including managing Financial SEC Reporting (10-K, 10-Q, ER) and Consolidation for ~200 legal entities worldwide.• Reporting to Assistant Controller, managing team of 10 accounting professionals• Managing financial reporting for several acquisitions and divestitures• Responsible for Accounting Development Program for graduates.
Jul 2012 - Feb 2015
Associate Director Consolidation And Financial Reporting
Consolidation and financial reporting for approximately 200 entities worldwide. Reporting to VP and Assistant Controller.
Nov 2009 - Jul 2012
Manager - Corporate Financial Reporting
Global project - Business Process Restructuring of Financial Close and Consolidation. Fully successful and delivered on time and within the budget.
Oct 2007 - Nov 2009
Regional Manager - General Accounting, Financial Shared Service
• European Shared Service - leading financial close for Germany, Austria, Belgium, Netherlands, Luxembourg and Switzerland.• Managing team of 8 accountants (multinational group)
Jul 2006 - Sep 2007
Country Accountant
Shared Service for BMS EMEA. Responsible for Poland, Estonia and Baltics.
Aug 2004 - Jun 2006
Accounting Supervisor
Setting up foreign companies for operating in Poland (legal entities, reporting, taxes, accounting, due diligence, payroll, tax compliance services).
Jun 1999 - Jul 2004
1 education record
Adam Bartnik education
-
Uniwersytet Marii Curie-Skłodowskiej W Lublinie
FAQ
Frequently asked questions about Adam Bartnik
Quick answers generated from the profile data available on this page.
What company does Adam Bartnik work for?
Adam Bartnik works for Reprieve Cardiovascular.
What is Adam Bartnik's role at Reprieve Cardiovascular?
Adam Bartnik is listed as CFO | Finance Executive with 20+ years in BioPharma | FP&A | R&D | Controller | Shared Services | International Experience at Reprieve Cardiovascular.
What is Adam Bartnik's email address?
AeroLeads has found 1 work email signal at @vrtx.com for Adam Bartnik at Reprieve Cardiovascular.
What is Adam Bartnik's phone number?
AeroLeads has found 1 phone signal(s) with area code 212 for Adam Bartnik at Reprieve Cardiovascular.
Where is Adam Bartnik based?
Adam Bartnik is based in Greater Boston, United States while working with Reprieve Cardiovascular.
What companies has Adam Bartnik worked for?
Adam Bartnik has worked for Reprieve Cardiovascular, Ascend Bio Advisors Llc, Vertex Pharmaceuticals, Bristol-Myers Squibb, and Tmf Group.
How can I contact Adam Bartnik?
You can use AeroLeads to view verified contact signals for Adam Bartnik at Reprieve Cardiovascular, including work email, phone, and LinkedIn data when available.
What schools did Adam Bartnik attend?
Adam Bartnik holds Master, Economics from Uniwersytet Marii Curie-Skłodowskiej W Lublinie.
What skills is Adam Bartnik known for?
Adam Bartnik is listed with skills including Financial Reporting, Us Gaap, Consolidation, Sap, Sarbanes Oxley Act, Finance, Accounting, and Financial Analysis.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial